Events
Jun 11, 2026
DCAT Global Summit
The future of bio/pharma: mastering the supply chain, digitalization, & global shifts
Made Scientific and Streamline Bio are building an integrated CDMO + automation offering for therapeutic developers, with the Early Adopter Program focused on early to late-phase cell therapy programs.
Let's Discuss How We Can Accelerate Your Cell Therapy Program with AI-Driven Robotic Automation